BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Genetronics, Inc. 

11494 Sorrento Valley Road

San Diego  California  92121-1334  U.S.A.
Phone: 858-597-6006 or 888-289-4363
Fax: 858-597-0119


SEARCH JOBS




Industry
Biotechnology

Segment
Drug Delivery

Collaborations

Johnson & Johnson  On October 6, 1998 Genetronics entered into comprehensive development and license agreements involving its proprietary drug delivery system for Electroporation Therapy treatment of cancer with Ethicon, Inc., a Johnson & Johnson company

Abbott Laboratories  On November 26, 1997, Genetronics announced a supply agreement with Abbott Laboratories allowing Genetronics to purchase the approved anti-cancer drug bleomycin for use with Genetronics MedPulser┬« drug delivery system in treatment of cancer.

Merck & Co., Inc.  DNA vaccine technology





 Company News
Genetronics Biomedical (GEB) Initiates Pancreatic Cancer Clinical Trial Using Its MedPulser Tumor Ablation System10/19/2005 5:12:53 PM
Genetronics Biomedical's (GEB) President And CEO To Present At Wells Fargo's 2005 Healthcare Conference10/19/2005 5:12:51 PM
Genetronics Biomedical (GEB) Announces Equity Financing10/19/2005 5:12:12 PM
Genetronics (GEB) And Vical Inc. (VICL) Establish Worldwide License For MedPulser(R) DNA Delivery System In Two Applications10/19/2005 5:11:56 PM
Genetronics' (GEB) President And CEO To Present At Rodman & Renshaw Techvest 6th Annual Global Healthcare Conference 10/19/2005 5:11:52 PM
Centient Investor Release: Biggest Biotech Winners And Losers During Q310/19/2005 5:11:49 PM
Genetronics (GEB) Granted FDA Fast Track Designation For Its MedPulser(R) Electroporation Therapy System For Head And Neck Cancer10/19/2005 5:11:38 PM
Genetronics (GEB) And Chiron Corporation (CHIR) Present Results On Electroporation-Enhanced DNA Vaccine Delivery At American Society of Gene Therapy Annual Meeting10/19/2005 5:11:36 PM
Genetronics (GEB) Appoints Senior Pharmaceutical Executive Walter Singleton As Vice President, Clinical And Regulatory Affairs10/19/2005 5:11:29 PM
Genetronics (GEB) And Merck & Co. (MRK) Sign Licensing Agreement For MedPulser(R) DNA Delivery System To Support DNA Vaccine Delivery10/19/2005 5:11:28 PM
123